Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-29

Clinical Trial Update: Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing [NA]

View source ↗

Summary

This clinical trial update describes a study sponsored by Ohio University to develop a tailored stigma-reduction intervention aimed at increasing buprenorphine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: Ohio University | Conditions: Opioid-Related Disorders, Buprenorphine | NA | Status: ACTIVE_NOT_RECRUITING